BioMarin to Participate in Upcoming Investor Conferences

• Wells Fargo 21st Annual Healthcare Conference, September 9 at 3:00 pm EST
• Cantor Global Healthcare Conference 2026, September 10 at 10:20 am EST
• Citi's 2026 Biopharma Back to School Conference, September 10 at 1:00 pm EST
• Morgan Stanley 24th Annual Global Healthcare Conference, September 14 at 10:00 am EST

SAN RAFAEL, Calif., Sept. 2, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at upcoming investor conferences in September.

An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference. 

BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients.

To learn more, please visit www.biomarin.com.

SOURCE BioMarin Pharmaceutical Inc.